DiabetologyNews.net

Diabetology Xagena

Xagena Mappa
Medical Meeting
Cardiobase
Dermabase.it

Search results for "Lixisenatide"

The EMA ( European Medicines Agency ) is investigating findings by a group of independent academic researchers that suggest an increased risk of pancreatitis ( inflammation of the pancreas ) and preca ...


Sanofi-Aventis has announced that Lixisenatide ( Lyxumia ) once-daily achieved primary efficacy endpoint and fewer hypoglycemias versus Exenatide ( Byetta ) twice-daily. The GetGoal-X Phase III stu ...


The efficacy and safety of Lixisenatide ( Lyxumia ), a once-daily prandial glucagon-like peptide-1 ( GLP-1 ) receptor agonist, in older patients with type 2 diabetes mellitus ( T2DM ) insufficiently c ...


The objective of a study was to evaluate the pharmacokinetics, efficacy and safety of Lixisenatide ( subcutaneous injection ) ( Lyxumia ) in elderly ( greater than or equal to 65 years old ) and very ...


New research presented at the annual meeting of the European Association for the Study of Diabetes ( EASD ) has shown how the glucose-lowering drug Lixisenatide ( Lyxumia ) can slow or prevent damage ...